Latest from Laurie McGinley

FDA review appears to pave the way for Pfizer-BioNTech vaccine for children 5 to 11

The authorization of a vaccine for school-aged children would open coronavirus vaccine eligibility to an estimated 28 million children in the United States.
  • Oct 22, 2021

FDA strongly considers authorizing vaccine boosters for people as young as 40

A decision is not likely until next month because of other pressing matters before the Food and Drug Administration.
  • Oct 20, 2021

Cold-weather states showing highest rate of new cases

Alaska is leading the low-temperature states with an increase in new infections, followed by Montana, Wyoming, Idaho and North Dakota.
  • Oct 19, 2021

FDA to allow ‘mix-and-match’ approach on coronavirus booster vaccines

The agency is rushing to make the announcement Wednesday as part of its authorization of boosters for Moderna and Johnson & Johnson vaccines.
  • Oct 18, 2021

Covid and cancer: A dangerous combination, especially for people of color

Doctors say people in low-income communities are showing up with advanced cancers because of pandemic-caused delays in diagnosis and treatment.
  • Oct 11, 2021

Top FDA official says boosters might be warranted for everyone 18 and older

The remarks came as the FDA prepares to meet Oct. 14 and 15 with its outside advisers to discuss boosters for the Moderna and Johnson & Johnson vaccines.
  • Oct 5, 2021

Johnson & Johnson seeks emergency authorization from FDA for coronavirus booster shot

The company is the last of the three vaccine companies to request permission for an extra shot.
  • Oct 5, 2021

White House moves to shield pandemic response if the government shuts down

Contingency staffing plans show that the FDA, CDC and NIH would continue their efforts to combat covid-19.
  • Sep 29, 2021

What to know about coronavirus booster shots in the U.S.

The Biden administration is rolling out coronavirus vaccine booster shots for certain groups
  • Sep 27, 2021